Bridgeway Capital Management’s Harvard Bioscience HBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.55K Sell
12,500
-77,017
-86% -$34.2K ﹤0.01% 1180
2025
Q1
$50.7K Sell
89,517
-39,800
-31% -$22.5K ﹤0.01% 1120
2024
Q4
$273K Sell
129,317
-55,183
-30% -$116K 0.01% 945
2024
Q3
$496K Hold
184,500
0.01% 863
2024
Q2
$526K Hold
184,500
0.01% 847
2024
Q1
$782K Sell
184,500
-13,900
-7% -$58.9K 0.02% 810
2023
Q4
$1.06M Hold
198,400
0.02% 742
2023
Q3
$853K Hold
198,400
0.02% 751
2023
Q2
$1.09M Hold
198,400
0.03% 708
2023
Q1
$833K Sell
198,400
-25,000
-11% -$105K 0.02% 765
2022
Q4
$619K Sell
223,400
-49,600
-18% -$137K 0.02% 847
2022
Q3
$699K Sell
273,000
-10,600
-4% -$27.1K 0.02% 811
2022
Q2
$1.02M Buy
283,600
+58,083
+26% +$209K 0.02% 724
2022
Q1
$1.4M Sell
225,517
-173,600
-43% -$1.08M 0.03% 697
2021
Q4
$2.81M Sell
399,117
-30,000
-7% -$212K 0.05% 497
2021
Q3
$3M Hold
429,117
0.06% 467
2021
Q2
$3.58M Buy
429,117
+89,200
+26% +$743K 0.06% 412
2021
Q1
$1.86M Sell
339,917
-67,600
-17% -$369K 0.03% 648
2020
Q4
$1.75M Sell
407,517
-147,500
-27% -$633K 0.04% 567
2020
Q3
$1.67M Sell
555,017
-75,000
-12% -$226K 0.04% 489
2020
Q2
$1.95M Buy
630,017
+3,800
+0.6% +$11.8K 0.04% 428
2020
Q1
$1.38M Sell
626,217
-19,400
-3% -$42.9K 0.03% 457
2019
Q4
$1.97M Hold
645,617
0.03% 564
2019
Q3
$1.99M Buy
645,617
+104,300
+19% +$321K 0.03% 512
2019
Q2
$1.08M Sell
541,317
-63,200
-10% -$126K 0.01% 712
2019
Q1
$2.61M Sell
604,517
-34,900
-5% -$150K 0.03% 440
2018
Q4
$2.03M Buy
639,417
+20,200
+3% +$64.2K 0.03% 503
2018
Q3
$3.25M Sell
619,217
-150,700
-20% -$791K 0.03% 449
2018
Q2
$4.12M Hold
769,917
0.04% 366
2018
Q1
$3.85M Sell
769,917
-66,000
-8% -$330K 0.04% 364
2017
Q4
$2.76M Buy
835,917
+50,300
+6% +$166K 0.03% 490
2017
Q3
$2.95M Buy
785,617
+79,400
+11% +$298K 0.03% 447
2017
Q2
$1.8M Buy
706,217
+191,500
+37% +$488K 0.02% 615
2017
Q1
$1.34M Buy
514,717
+145,700
+39% +$379K 0.02% 710
2016
Q4
$1.13M Buy
369,017
+115,000
+45% +$351K 0.01% 772
2016
Q3
$691K Buy
254,017
+2,900
+1% +$7.89K 0.01% 951
2016
Q2
$718K Hold
251,117
0.01% 898
2016
Q1
$758K Hold
251,117
0.01% 883
2015
Q4
$871K Buy
251,117
+50,000
+25% +$173K 0.02% 818
2015
Q3
$760K Sell
201,117
-350
-0.2% -$1.32K 0.02% 845
2015
Q2
$1.15M Hold
201,467
0.02% 730
2015
Q1
$1.17M Buy
201,467
+350
+0.2% +$2.04K 0.02% 720
2014
Q4
$1.14M Hold
201,117
0.03% 723
2014
Q3
$823K Hold
201,117
0.02% 836
2014
Q2
$915K Hold
201,117
0.02% 802
2014
Q1
$953K Hold
201,117
0.03% 779
2013
Q4
$945K Sell
201,117
-64,156
-24% -$301K 0.03% 766
2013
Q3
$1.06M Buy
265,273
+1,714
+0.7% +$6.84K 0.04% 701
2013
Q2
$939K Buy
+263,559
New +$939K 0.04% 663